SCHEMBL712190

SCHEMBL712190

O=c1ccn(S)c(=O)n1-c1ccccc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3A P49840 7/20 0.45
GSK3B P49841 7/20 0.45
GAA P10253 1/20 0.42
MAPK1 P28482 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.40
EP300 Q09472 1/20 0.38
KAT2B Q92831 1/20 0.38
ALDH1A1 P00352 1/20 0.38
CYP3A4 P08684 1/20 0.37
CYP2D6 P10635 1/20 0.37
MAPT P10636 1/20 0.37
PGR P06401 1/20 0.36
NTRK1 P04629 1/20 0.35
IGF1R P08069 1/20 0.35
FGFR1 P11362 1/20 0.35
NTRK3 Q16288 1/20 0.35
NTRK2 Q16620 1/20 0.35
KDM4E B2RXH2 1/20 0.34
ATM Q13315 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5868283 0.80 GSK3A (0.45) GSK3AGSK3BGAAMAPK1SMN1; SMN2
SCHEMBL31580031 0.76 GSK3B (0.55) GSK3AGSK3BGAAMAPK1CYP3A4
SCHEMBL7712655 0.76 GSK3A (0.45) GSK3AGSK3BGAAMAPK1SMN1; SMN2
SCHEMBL19377760 0.72 GSK3B (0.46) GSK3AGSK3BGAAMAPK1SMN1; SMN2
SCHEMBL1722780 0.70 GSK3B (0.71) GSK3AGSK3BGAAMAPK1ALDH1A1
SCHEMBL3807230 0.68 ALDH1A1 (0.41) GSK3AGSK3BGAAMAPK1ALDH1A1
SCHEMBL6645924 0.68 GSK3A (0.45) GSK3AGSK3BGAAMAPK1SMN1; SMN2
SCHEMBL6226538 0.68 SMN1; SMN2 (0.48) GSK3AGSK3BGAASMN1; SMN2EP300
SCHEMBL24205248 0.65 GSK3A (0.39) GSK3AGSK3BSMN1; SMN2ALDH1A1MAPT
SCHEMBL5306506 0.65 MAPK1 (0.71) GSK3AGSK3BGAAMAPK1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8252925-B2 Method for the production of 3-phenyl(thio)uracils and dithiouracils BASF AKTIENGESELLSCHAFT (DE) 2012-08-28 US claimed
US-7737275-B2 Method for producing 3-phenyl(thio)uracils and 3-phenyldithiouracils BASF AKTIENGESELLSCHAFT (DE) 2010-06-15 US claimed
US-20080033174-A1 Method for the Production of 3-Phenyl (Thio) Uracils and Dithiouracils BASF AKTIENGESELLSCHAFT (DE) 2008-02-07 US claimed
EP-1692115-B1 METHOD FOR PRODUCING 3-PHENYL(THIO)URACILS AND 3-PHENYLDITHIOURACILS BASF AG (DE) 2007-12-19 EP claimed
EP-1773787-A1 METHOD FOR THE PRODUCTION OF 3-PHENYL(THIO)URACILS AND DITHIOURACILS BASF AKTIENGESELLSCHAFT (DE) 2007-04-18 EP claimed
US-20060293520-A1 Mehtod for producing 3-phenyl(thio)uracils and 3-phenyldithiouracils BASF AKTIENGESELLSCHAFT (DE) 2006-12-28 US claimed
EP-1692115-A1 METHOD FOR PRODUCING 3-PHENYL(THIO)URACILS AND 3-PHENYLDITHIOURACILS BASF AKTIENGESELLSCHAFT (DE) 2006-08-23 EP claimed
WO-2006010474-A1 METHOD FOR THE PRODUCTION OF 3-PHENYL(THIO)URACILS AND DITHIOURACILS BASF AKTIENGESELLSCHAFT (DE) 2006-02-02 WO claimed
WO-2005054208-A1 METHOD FOR PRODUCING 3-PHENYL(THIO)URACILS AND 3-PHENYLDITHIOURACILS BASF AKTIENGESELLSCHAFT (DE) 2005-06-16 WO claimed
CN-1989111-B Method for the production of 3-phenyl(thio)uracils and dithiouracils BASF AG 2012-12-05 CN disclosed
CN-1989111-B Method for the production of 3-phenyl(thio)uracils and dithiouracils BASF AG 2012-12-05 CN disclosed
US-8252925-B2 Method for the production of 3-phenyl(thio)uracils and dithiouracils BASF AKTIENGESELLSCHAFT (DE) 2012-08-28 US disclosed
US-8252925-B2 Method for the production of 3-phenyl(thio)uracils and dithiouracils BASF AKTIENGESELLSCHAFT (DE) 2012-08-28 US disclosed
US-8252925-B2 Method for the production of 3-phenyl(thio)uracils and dithiouracils BASF AKTIENGESELLSCHAFT (DE) 2012-08-28 US disclosed
EP-1692115-A1 METHOD FOR PRODUCING 3-PHENYL(THIO)URACILS AND 3-PHENYLDITHIOURACILS BASF AKTIENGESELLSCHAFT (DE) 2006-08-23 EP disclosed
EP-1692115-A1 METHOD FOR PRODUCING 3-PHENYL(THIO)URACILS AND 3-PHENYLDITHIOURACILS BASF AKTIENGESELLSCHAFT (DE) 2006-08-23 EP disclosed
WO-2006010474-A1 METHOD FOR THE PRODUCTION OF 3-PHENYL(THIO)URACILS AND DITHIOURACILS BASF AKTIENGESELLSCHAFT (DE) 2006-02-02 WO disclosed
WO-2006010474-A1 METHOD FOR THE PRODUCTION OF 3-PHENYL(THIO)URACILS AND DITHIOURACILS BASF AKTIENGESELLSCHAFT (DE) 2006-02-02 WO disclosed
WO-2005054208-A1 METHOD FOR PRODUCING 3-PHENYL(THIO)URACILS AND 3-PHENYLDITHIOURACILS BASF AKTIENGESELLSCHAFT (DE) 2005-06-16 WO disclosed
WO-2005054208-A1 METHOD FOR PRODUCING 3-PHENYL(THIO)URACILS AND 3-PHENYLDITHIOURACILS BASF AKTIENGESELLSCHAFT (DE) 2005-06-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060293520-A1 Mehtod for producing 3-phenyl(thio)uracils and 3-phenyldithiouracils HPRT1, TH, METTL3 GSK3A 4469/4885GSK3B 4728/4885GAA 3726/4885
US-20080033174-A1 Method for the Production of 3-Phenyl (Thio) Uracils and Dithiouracils TPMT, TYMP, TYMS GSK3A 4489/4885GSK3B 4488/4885GAA 1862/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.